Fibrocell Science, Inc. — Operating Income by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8a019816-4b65-4857-ad1a-d3f6b852ce85/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2018 | $-12.4M | 2018-01-01 – 2018-12-31 | evidence 0001628280-19-003496 |
| FY 2017 | $-19.0M | 2017-01-01 – 2017-12-31 | evidence 0001628280-18-003348 |
| FY 2016 | $-26.5M | 2016-01-01 – 2016-12-31 | evidence 0000357097-17-000033 |
| FY 2015 | $-37.4M | 2015-01-01 – 2015-12-31 | evidence 0000357097-16-000133 |
| FY 2014 | $-30.0M | 2014-01-01 – 2014-12-31 | evidence 0000357097-15-000016 |
| FY 2013 | $-30.5M | 2013-01-01 – 2013-12-31 | evidence 0001144204-14-015946 |
| FY 2012 | $-29.4M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-135295 |
| FY 2011 | $-20.0M | 2011-01-01 – 2011-12-31 | evidence 0001193125-13-135295 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).